StockData
Scinai Immunotherapeutics Ltd. logo

Scinai Immunotherapeutics Ltd. (SCNI) stock

SCNINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 6/30
$0.37−0.03 (-7.82%)

Close on Nov 17, 2026Market cap $1.29MP/E –Yield –

Scinai Immunotherapeutics total assets

Total assets on the balance sheet at the end of each period.

Scinai Immunotherapeutics's total assets was $17.18M at Jun 30, 2026. For fiscal 2025 it was $11.63M, down 13.5% from the year before. The highest annual figure on record is $32.04M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$11.63M-13.5%
FY2024Dec 31, 2024$13.45M-23.0%
FY2023Dec 31, 2023$17.47M-35.4%
FY2022Dec 31, 2022$27.07M-15.5%
FY2021Dec 31, 2021$32.04M+81.0%
FY2020Dec 31, 2020$17.70M-24.9%
FY2017Dec 31, 2017$23.56M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$17.18M+15.6%
Q4 FY2025Dec 31, 2025$11.63M-33.5%
Q2 FY2025Jun 30, 2025$11.84M-40.5%
Q4 FY2024Dec 31, 2024$13.45M-42.3%
Q2 FY2024Jun 30, 2024$14.85M-45.1%
Q4 FY2023Dec 31, 2023$17.47M-28.5%
Q2 FY2023Jun 30, 2023$19.90M-37.9%
Q1 FY2023Mar 31, 2023$23.29M-7.2%
Q4 FY2022Dec 31, 2022$27.07M+52.9%
Q2 FY2022Jun 30, 2022$24.45M+3.8%
Q4 FY2021Dec 31, 2021$32.04M–
Q3 FY2021Sep 30, 2021$25.09M–
Q4 FY2020Dec 31, 2020$17.70M–
Q4 FY2017Dec 31, 2017$23.56M–

More Scinai Immunotherapeutics figures

See a number that looks wrong?